Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
05 November 2024 - 8:30AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
Form
6-K
Report
of Foreign Private Issuer
Pursuant
to Rule 13a-16 or 15d-16
of
the Securities Exchange Act of 1934
For
the month of November 2024
Commission
File Number: 001-40614
INTERCURE
LTD.
(Translation
of registrant’s name into English)
85
Medinat ha-Yehudim Street
Herzliya,
4676670, Israel
Tel:
+972 77 460 5012
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
On November
4, 2024, an Extraordinary General Meeting of Shareholders of Intercure Ltd. (the “Company”) approved each of the eight proposals
brought before the Company’s shareholders at the meeting, in accordance with the majority required for each proposal. Each of those
proposals was described in the Company’s Notice and Proxy Statement with respect to the Company’s Extraordinary General Meeting
of Shareholders, which was initially published on September 13, 2024, and subsequently amended on September 17, 2024, as reflected in
Exhibit 99.1 to the Company’s Form 6-K/A that was furnished to the U.S. Securities and Exchange Commission on September 17, 2024.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
| |
INTERCURE
LTD. |
| |
|
| Date:
November 4, 2024 |
/s/
Amos Cohen |
| |
Amos
Cohen
|
| |
Chief
Financial Officer |
Intercure (NASDAQ:INCR)
Historical Stock Chart
From Dec 2024 to Jan 2025
Intercure (NASDAQ:INCR)
Historical Stock Chart
From Jan 2024 to Jan 2025
